Brief: aTyr Pharma Q1 Net Income USD -15.487 Million
02/05/2024 21:00
May 02 (Reuters) - aTyr Pharma Q1 operating expenses USD 16.871 million. * Q1 income from operations USD -16.636 million * Q1 basic EPS USD -0.23
Recent news on aTyr Pharma
See all newsBrief: Atyr Pharma Announces Research Collaboration With Montefiore Einstein
U.S. STOCKS ON THE MOVE-Charles River, Oracle, TD Synnex
US STOCKS ON THE MOVE-Charles River, Oracle, TD Synnex
U.S. STOCKS ON THE MOVE-CoreWeave, Versant Media, BlackBerry
aTyr rises as FDA aligns on late-stage lung disease study plan